PDT Partners’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.44M | Buy |
332,815
+56,755
| +21% | +$758K | 0.25% | 136 |
|
|
2025
Q1 | $2.81M | Buy |
+276,060
| New | +$2.81M | 0.2% | 178 |
|
|
2023
Q2 | – | Sell |
-22,657
| Closed | -$967K | – | 619 |
|
|
2023
Q1 | $967K | Buy |
22,657
+56
| +0.2% | +$2.39K | 0.13% | 270 |
|
|
2022
Q4 | $1.09M | Sell |
22,601
-62
| -0.3% | -$2.98K | 0.18% | 201 |
|
|
2022
Q3 | $853K | Sell |
22,663
-24,883
| -52% | -$937K | 0.13% | 267 |
|
|
2022
Q2 | $1.31M | Buy |
47,546
+30,391
| +177% | +$840K | 0.12% | 299 |
|
|
2022
Q1 | $933K | Buy |
+17,155
| New | +$933K | 0.08% | 401 |
|
|
2021
Q2 | – | Sell |
-3,876
| Closed | -$239K | – | 893 |
|
|
2021
Q1 | $239K | Buy |
+3,876
| New | +$239K | 0.02% | 664 |
|